However, current method assessing HER2 status either by using immunohistochemistry (IHC) or by fluorescence in situ hybridization (FISH) in tumor specimens obtained from surgical resection or endoscopic biopsy involves invasive procedures. The gene discussed is ERBB2; the disease is neoplasm.